Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic

BACKGROUND: Immunomodulatory therapy (IMT) is often considered for systemic treatment of non-infectious uveitis (NIU). During the evolving coronavirus disease-2019 (COVID-19) pandemic, given the concerns related to IMT and the increased risk of infections, an urgent need for guidance on the manageme...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Ophthalmol
Main Authors: Agrawal, Rupesh, Testi, Ilaria, Lee, Cecilia S, Tsui, Edmund, Blazes, Marian, Thorne, Jennifer E, Okada, Annabelle A, Smith, Justine R, McCluskey, Peter J, Kempen, John H, Tappeiner, Christoph, Agarwal, Manisha, Bodaghi, Bahram, Nguyen, Quan Dong, Gupta, Vishali, De Smet, Marc D, Zierhut, Manfred, Pavesio, Carlos
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Clinical Science
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7313529/
https://ncbi.nlm.nih.gov/pubmed/32586933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2020-316776
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados